June 13, 2025

RSV Vaccine Approved for Younger Adults

The FDA has approved Moderna’s mRESVIA vaccine for adults aged 18 to 59 who are at increased risk for RSV, expanding its indication beyond older adults.

Conexiant

June 12, 2025

Vegetarian Diet Linked to Lower Cancer Incidence

A large North American cohort study found that vegetarian diets were associated with lower risks of several site-specific cancers, including colorectal, stomach, breast, prostate, and lymphoproliferative cancers.

Conexiant

June 11, 2025

8-Week Oral Therapy Approved for Acute HCV

The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention.

Conexiant

June 06, 2025

RSV or COVID: Which Strains the Heart?

A study of 32,960 hospitalizations finds 10.9% of patients with RSV experienced acute cardiovascular events, with significantly higher adjusted odds than boosted and unboosted COVID-19 cases.

Conexiant

June 05, 2025

Can Adolescent Diets Predict Fatherhood?

New research shows fathers who improved their diet as teenagers were more likely to promote healthy eating in their children and had kids who ate more fruits and vegetables.

Conexiant

June 04, 2025

Restrictive Eating Tied to Depression in Men

A UK study found that dietary restraint is linked to higher depressive symptoms, with stronger effects seen in men and individuals with elevated BMI.

Conexiant

June 04, 2025

Oat Fiber Intake Tied to PFAS Reduction

A Canadian study found widespread PFAS exposure in adult men and observed that a four-week oat fiber intervention modestly reduced some long-chain PFAS levels in blood, with liver enzyme elevations linked to certain PFAS types.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

June 02, 2025

PrEP Users With AUD Under-Treated, Study Finds

Researchers found that nearly 15% of commercially insured PrEP users had an alcohol use disorder diagnosis, yet fewer than 9% received FDA-approved treatment.

Conexiant